|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D bio-ink printing (1) | 3D QSAR (1) |
| 3D-QSAR (1) | 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) |
| 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) | 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) |
| 5-fluoroindolin-2-one (1) | 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) |
| 5-Piperazinedione (1) | 6 (1) | 6-beta naltrexol (1) |
| 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) |
| 7 (1) | 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) |
| 99mTc-ciprofloxacin (1) | A. nilotica (1) | ABC analysis (5) |
| ABC-VED matrix (4) | ABC-VEN analysis (1) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| ABTS (1) | Abuse (1) | Academic Stressors scale (1) |
| Acalypha indica (1) | Acarbose (1) | Accuracy. (1) |
| Accurate (1) | ACE (2) | ACE inhibitor (1) |
| Aceclofenac (1) | ACEIs (1) | Acetaminophen (1) |
| Acetazolamide (1) | Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) |
| Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) | Acetylation rate (1) |
| Acetylcholinesterase (4) | Acetylcholinesterase inhibitors (1) | ACF (1) |
| Acid hydrolysis (1) | Acid violet 43 (1) | Acid-resistant capsules (1) |
| Acne (2) | Acne vulgaris (1) | Aconitine (1) |
| Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Act score (1) |
| Actinomycetes (1) | Activator procaspase-3 (1) | active pharmaceutical ingredient (1) |
| Active site (1) | Activities of daily living (ADL) scale (1) | Activity domain (1) |
| Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
| Acute Inflammation (1) | Acute inß ammation (1) | Acute Kidney Damage (1) |
| Acute poisoning (1) | Acute Severe Pancreatitis (1) | Acute Side Effects (1) |
| Acute ST segment elevation myocardial infarction (1) | Acute toxicity (1) | acyclovir (2) |
| ADE (1) | Adenanthera (1) | Adenosine A 2A antagonist (1) |
| Adherence (5) | Adherence. (1) | Adiantum venustum (1) |
| Adjuvant therapy (1) | ADME properties. (1) | Adnexal masses (1) |
| ADR (2) | ADR (Adverse Drug Reaction) (3) | ADR management (1) |
| ADR monitoring centre (AMC). (1) | ADR reporting (1) | ADR(Adverse Drug Reaction) (1) |
| ADRs (2) | Adsorbent (1) | Adverse drug event (1) |
| adverse drug events (1) | Adverse drug reaction (14) | Adverse Drug Reaction (ADR) (1) |
| Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse Drug Reaction Reporting Systems (2) | Adverse drug reaction. (1) |
| Adverse Drug Reactions (10) | Adverse drug reactions (ADRs) (1) | Adverse effects (1) |
| Adverse event following immunization (AEFI) (1) | Adverse events (2) | Adverse reaction (1) |
| Aedes aegypti (2) | Aerobic exercise (1) | Aerosil (1) |
| affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (2) | Ageratum conyzoides L (1) |
| Agrobacterium (1) | air pollution (1) | Airjet (1) |
| Albendazole (1) | Albino mice (1) | Albino wistar rats (1) |
| Albumin Denaturation (1) | Alcohol (2) | Alcohol withdrawl seizure (1) |
| alcoholic extract (1) | ALDEN (1) | Aldose reductase inhibitors (1) |
| Alkaloids (1) | allantoin (1) | Allergic reactions (1) |
| Allergic rhinitis (1) | Allergy (4) | Allium sativum (1) |
| Alloxan (1) | Alloxan monohydrate (1) | Alocasia indica Schott (1) |
| Aloe vera (1) | Alpha mangostin (1) | Alpha-adrenoceptor (1) |
| alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
| Alteration of drug cost (1) | Altered Mental Status (AMS) (1) | alternative therapy (1) |
| Aluminium chloride (2) | Alzheimer's disease (1) | Alzheimers disease (1) |
| Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) | Amber (1) |
| Ambroxol hydrochloride (1) | Ambulatorial Surgery Procedures (1) | Amides (1) |
| Amikacin Sulfate (1) | Amino acids (1) | amino benzylated Mannich bases (1) |
| Amisulpride (1) | amivudine (1) | Amlodipine (2) |
| Amlodipine besylate (2) | Ammonium salts (1) | Amoora cucullata. (1) |
| amoxicillin (1) | Amoxicillin - clavulanic acid (1) | Amoxicillin sodium (1) |
| Anabolic steroids (1) | Anabolic. (1) | Anaemia (2) |
| Analgesia (1) | analgesic (9) | Analgesic effect (1) |
| analgesic- anti-inß ammatory activity (1) | Analgesics (1) | Analysis in capsules (1) |
| Analysis of variance (1) | Analytical methods (1) | Anaphylactic shock (1) |
| Anaphylaxis. (1) | and TGF–β (1) | Andragogy (1) |
| Anemia (2) | Anethole (1) | Anethum graveolens (1) |
| Angiogenesis (1) | Angiogenic growth factors (1) | Angiotensin Converting Enzyme Inhibitors (1) |
| Animal model (1) | Ankylosing spondylitis (1) | antepartum (1) |
| anthelmintic (1) | anthelmintic property (1) | Anthocyanin (1) |
| Anthracyclines (2) | Anti aging (1) | Anti hyperglycemic (1) |
| Anti inflammatory (1) | Anti-amnesia (2) | anti-anxiety activity (1) |
| Anti-anxiolytic (1) | Anti-asthmatic activity (1) | Anti-Cancer Activity (1) |
| Anti-diabetes mellitus. (1) | Anti-diabetic drugs (1) | Anti-epileptic (1) |
| Anti-epileptic drugs utilization (1) | Anti-HIV (2) | anti-hypertensive agent (1) |
| Anti-infective (2) | Anti-infective agents (1) | anti-inflammation (1) |
| anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) | anti-inflammatory activity (2) |
| anti-inflammatory activity', (1) | anti-inflammatory agent (1) | anti-inß ammatory (3) |
| Anti-inß ammatory activity (1) | Anti-obesity (1) | Anti-oxidant (2) |
| Anti-parkinsonism activity (1) | Anti-solvent (1) | anti-spasmodic drug (1) |
| Anti-TB drugs (1) | Anti-tubercular activity (1) | Anti-tumor agent (1) |
| antiamnesic agents (1) | Antianxiety (1) | antibacterial (3) |
| antibacterial activity (4) | Antibacterial drugs (1) | Antibiotic (2) |
| antibiotic guidelines (1) | Antibiotic paste (1) | Antibiotic Resistance (3) |
| Antibiotic Sensitivity (1) | Antibiotics (9) | Antibiotics. (1) |
| Anticancer (5) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (2) | Anticoagulant service (1) |
| anticonvulsant (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (1) |
| Antidiabetic (3) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| Antiepileptic (1) | antiepileptic agents (1) | Antiepileptic Drugs (3) |
| antifungal (1) | antifungal activity (1) | Antifungal drugs (1) |
| Antigen (1) | antigen protein (1) | Antiglycation (1) |
| Antihistaminic (2) | Antihyperglycemic (1) | Antihypertensive (1) |
| Antihypertensives (1) | Antiinflamatory (1) | Antimalarial (2) |
| Antimicrobial (4) | Antimicrobial activities (1) | Antimicrobial activity (7) |
| Antimicrobial agent (1) | Antimicrobial efficacy (1) | Antimicrobial resistance (2) |
| Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) | Antimicrobial Stewardship (1) | Antimicrobials (4) |
| Antimosquito (1) | Antimycotic Activity (1) | antinociceptive (1) |
| Antioxidant (19) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (8) |
| antioxidant effect (1) | Antioxidant properties (1) | Antioxidants (6) |
| Antipsychotics (1) | antipyretic (2) | Antiretroviral drugs (1) |
| Antiretroviral therapy (2) | Antispasmodic (1) | Antithrombotic (2) |
| Antithyroid drugs (1) | Antitubercular (1) | Antitubercular drugs. (1) |
| antiulcer (1) | Antiurolithiatic activity (1) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (2) | antiviral activity (2) |
| Antiviral RNA (1) | Anti– microbials (1) | Anxiety (4) |
| Anxiolytics (1) | APAP (1) | APC (1) |
| Apoptosis (2) | Application (1) | Application to PK profile studies (1) |
| applications (1) | Appropriateness (1) | Aqueous extract (3) |
| AR Caps (1) | Arabic gum (1) | ARBs (1) |
| ARDS (1) | Area above the blood glucose levels-time curve. (1) | area of wound healing (1) |
| Areca nut (1) | Arginase (2) | Arginine (1) |
| Aripiprazole (1) | Armodafinil (1) | ART (1) |
| Artemia salina (1) | Artemia salina. (1) | Artemisia (1) |
| Artemisia absinthium (1) | Artemisia macrocephala (1) | arterial hypertension (1) |
| Arterial stiffness (2) | Arteriovenous malformation (AVM) (1) | Arthralgia (1) |
| Arthritis (1) | ARV Drugs (1) | Ascorbic acid (3) |
| Asenapine (1) | asian developing nations (1) | Asiaticoside (1) |
| Asparagus racemosus (1) | Asparagus racemosus root extract (1) | Aspergillus niger (2) |
| Aspergillus niger. (1) | Aspergillus terreus (1) | Aspirin (1) |
| Assay (2) | Asthma (6) | Asymptomatic neurocognitive impairment (1) |
| Ataxia (3) | ATC/DDD (3) | Atenolol (1) |
| Atherosclerosis (1) | Atherosclerotic Vascular Disease (1) | Athlete Biological Passport (1) |
| Atorvastatin (5) | Atorvastatin calcium (1) | Atorvastatin. (1) |
| ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) | Atractylis flava Desf (1) |
| Atrial fibrillation (1) | Atropine (1) | Attitude (7) |
| Attitude and practice (1) | Attitude. (1) | Attitudes (1) |
| Atypical antipsychotics (1) | Aucubin (1) | Authors (1) |
| Authorship issues (1) | Autism spectrum disorders (1) | Auto antibody (1) |
| Auto medication (1) | Autoimmune disorders (1) | Autoimmunity (1) |
| Averrhoa bilimbi (1) | Avicel (1) | Awareness (5) |
| Ayurveda (2) | Ayurvedic (1) | Azelaic acid (1) |
| Azilsartan medoxomil (1) | B cell epitope (1) | Bacoside A3 (1) |
| Bacteremia (1) | Bacteria (1) | Bacterial contamination (1) |
| Bacterial isolates (1) | Bacteriological culture (1) | Bacteriostatic (1) |
| Baker Venkataraman transformation (1) | Bamboo betung (1) | Bambusa vulgaris (1) |
| Banana (1) | Bangladesh (2) | bark (1) |
| Barleria cristata (1) | Barriers (1) | Bauhinia purpurea (1) |
| Bauhinia racemosa (1) | Bauhinia variegata (2) | Bay-K-8644 (1) |
| Bayesian confidence propagation neural network (1) | BCG vaccine (1) | BCS-IV drug (1) |
| Beauty Salon Owner (1) | Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) |
| Bedaquiline (1) | Behavioral research (1) | Belief (1) |
| Benchmarking (1) | Benzimidazole derivative (1) | benzimidazoles (2) |
| Benzodiazepines (1) | Benzothiazole analogues (1) | Benzo[d]oxazole-2-thiol (1) |
| Berberis integerrima Bunge (1) | Beta-lactamase (1) | Beta-lactamic (1) |
| Bibliometrics (5) | BIBN4096 (1) | Bilayered floating tablets (1) |
| Bioactive compound (1) | Bioactive Metabolites (2) | Bioactivity (1) |
| Bioadhesive (1) | Bioanalytical (1) | Bioanalytical method (2) |
| Bioanalytical method development (1) | Bioassay (1) | bioavailability (5) |
| Biodegradable (1) | Bioethics (1) | Biofilm (1) |
| Biohazard (1) | Biologics (1) | Biology (1) |
| Biomaterials (1) | Biomedical (1) | Bioprospecting. (1) |
| Biopsy Proven Acute Rejection (1) | Biosafety (1) | Biosafety Engineering Control (1) |
| Biosimilars (2) | Biotechnology (2) | Bisphosphonates (1) |
| Bitter (1) | Black Garlic (1) | Black tea extract (1) |
| BLAST (1) | Bleaching (1) | Bleeding time (1) |
| Bleomycin (1) | Blonanserin (1) | Blood brain barrier (1) |
| Blood donor (1) | Blood glucose (1) | Blood pressure (4) |
| Blood safety (1) | Blue and red from (1) | Body Mass Index (1) |
| Body Mass Index (BMI). (1) | Boerhaavia Diffusa (1) | Bone (2) |
| Book Review (1) | Borg scale (1) | botulinum toxin (1) |
| Box-Behnken (1) | Brahmi vati (1) | Brain (1) |
| Brain targeting (2) | Brand Drugs (1) | brand name drugs (1) |
| Branded medication (1) | Bratton-Marshall reagent (1) | Brazil (1) |
| Breast cancer (6) | Breastfeeding (1) | Brewer’s yeast (1) |
| Brief COPE scale (1) | Brief medication questionnaire (1) | Brimonidine tartrate (1) |
| brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (2) |
| Bryonia laciniosa (1) | Buccal (1) | Buccal Patches (1) |
| budget forecasting (1) | Bufadienolide (1) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Bungur (1) |
| Buni-berry extract (1) | Buoyancy (1) | Buoyant microspheres (1) |
| Burden Of Disease (1) | Business method (1) | Business model (1) |
| Butea monosperma (1) | C-reactive protein (1) | C. albicans (1) |
| C60 derivatives (1) | C934 (1) | CA125 (1) |
| Ca2+ channels (1) | Cadmium chloride (1) | Caesalpinia decapetala (1) |
| Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) | Caesalpinia sappan (1) |
| CAGR (1) | Calcineurin inhibitor (1) | Calcium (1) |
| Calcium channel blocking (1) | calcium channel blocking activity (1) | Calcium oxalate (1) |
| Calcium phosphate (1) | Calcium silicate (1) | Calendula officinalis (1) |
| calendula oil (1) | CAM Assay (1) | Camelia sinensis extract (1) |
| Camellia sinensis (1) | Camptothecin (1) | Canagliflozin (1) |
| Cancer (7) | Cancer Chemotherapy (2) | Cancer treatment (1) |
| Candida (2) | Candida albicans (4) | Candida albicans. (1) |
| CaOx crystal aggregation (1) | CaOx crystal nucleation (1) | Capacity (1) |
| Capsule (1) | capsules (1) | carbamazepin (1) |
| Carbamazepine (3) | carbohydrazide (1) | Carbomyl Linkage (1) |
| carbon tetrachloride (1) | carbonyl compounds (1) | Carbopol (1) |
| Carbopol 940 (1) | Carcinogenic substances (1) | Carcinoma. (1) |
| cardiac arrhythmias (1) | Cardiac care (1) | Cardiac remodeling (1) |
| Cardiology (2) | Cardioprotection (1) | Cardioprotective (1) |
| Cardiotoxicity (2) | Cardiovascular disease (1) | Cardiovascular drugs (1) |
| Career Choices (1) | Carica papaya L. (1) | Carnaúba (1) |
| Carnauba wax (1) | carrageenan (2) | Caryocar coriaceum (1) |
| Case report (1) | Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) |
| Catalase (1) | catalepsy (2) | Cation-pi (1) |
| CationicGuargum (1) | Caulerpa lentillifera (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CD150 (1) |
| CD244.2 (1) | CD48 (1) | Cefixime (1) |
| Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) | Cefuroxime (1) |
| Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) | Cellulase (1) |
| Cellulite (1) | Cellulitis (1) | Cellulose (2) |
| Cemented (1) | Cementless (1) | CEN (1) |
| Centella asiatica (3) | Central composite design (4) | Central cord syndrome (1) |
| Central post-stroke pain (1) | Cephalexin (2) | Ceramics (1) |
| Cerebrovascular Accident (1) | Cervical bulge (1) | Cervical dentine hypersensitivity (1) |
| CFFF (1) | CGRP (1) | chalcone (1) |
| chalcones (2) | Challenges (1) | Chamomile tea (1) |
| Characterization (4) | Chebulinic acid (1) | Chemical stability (1) |
| Chemiluminescence (1) | Chemomechanical removal (1) | Chemometrics (3) |
| Chemotaxis (1) | Chemotherapy (7) | Chewable tablets (1) |
| Chewing gum (1) | Child Care (1) | Childhood cancer (1) |
| Children (2) | Children Dentistry (1) | Chitin (1) |
| Chitosan (8) | Chitosan Acetate. (1) | chitosan microspheres (1) |
| Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) |
| Chloramphenicol (1) | Chlorhexidine (2) | Chlorohexidine (1) |
| cholesterol (1) | Cholesterol HDL (1) | Cholinesterase inhibitors (1) |
| Chromatography (1) | Chromotropic acid reagent (1) | Chronic hepatitis B (1) |
| Chronic kidney disease (2) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) |
| Cicer arietinum (1) | Cigarette smoke (1) | Cilostazol (1) |
| Cinnamaldehyde (1) | Cinnamic acid derivatives (1) | Cinnamomum cassia (1) |
| Ciprofloxacin (1) | Citronella (1) | Citrus hystrix (1) |
| Citrus limon (2) | CKD (1) | CKMB. (1) |
| Claims (1) | Clarithromycin (1) | Classification (1) |
| Clastogenicity (1) | Cleistanthin A (2) | cleistanthin B (2) |
| Cleistanthus Collinus (1) | Clinical attachment (1) | Clinical attachment level (1) |
| Clinical efficacy (1) | Clinical equivalence (1) | Clinical manifestation (1) |
| Clinical Pharmacist (1) | Clinical pharmacist care (1) | Clinical Pharmacists (1) |
| Clinical pharmacology (1) | Clinical Pharmacy (1) | Clinical Pharmacy Services (1) |
| Clinical research (1) | Clinical trial (1) | Clinical trials (1) |
| Clinicians (1) | clonidine (2) | Clopidogrel (1) |
| Clopidogrel bisulfate (1) | Closed melt (1) | Clove (1) |
| cloxacillin (1) | Cluster analysis (1) | CME (1) |
| CNC (1) | CNF (1) | CNS stimulants (1) |
| Co-crystal (1) | Co-Formers (1) | Co-Morbidity (1) |
| Co-morbidity. Correspondence (1) | co-precipitation method (1) | Co-surfactant (1) |
| Cochlopermum tinctorium (1) | coding system (1) | Cognition (2) |
| Cognitive impairment (1) | Cogrinding (1) | Colloidal carriers (1) |
| Colloidal silicone dioxide (1) | Colon targeted delivery (1) | Colon targeted drug delivery. (1) |
| Colon targeting (1) | Colonic delivery (1) | Colorectal cancer (1) |
| colorimetric assay (1) | Column chromatography (1) | Combination tablet (1) |
| Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
| common cold (1) | common cold and cough (1) | Common warts (1) |
| Community Pharmacies (2) | Community pharmacist (3) | Community Pharmacists (2) |
| Community pharmacy (2) | Community Pharmacy Patient Questionnaire (1) | Comorbidity (1) |
| Comparative dissolution (1) | comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) |
| Comparison (1) | compensation (1) | Complementary and alternative medicine (2) |
| complementary and alternative medicines (1) | Complementary and alternative therapy (1) | complete epithelization (1) |
| Complexation (1) | Compliance (1) | compound 48/80 (2) |
| compritol 888 ATO (1) | Computer (1) | Computer literacy (1) |
| computer-aided instructions (1) | Computer-aided learning (1) | Computerized screening systems (1) |
| CoMSIA (1) | Conessine (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | Consumer side effects reporting from (1) |
| Consumer’s Perception (1) | Content validation (1) | content validity (1) |
| continuing education (2) | Continuous Pharmacy Education. (1) | Contract research (1) |
| Contract research organizations (1) | Control (1) | Controlled release (4) |
| convolution (1) | convulsions (1) | cooperative practice (1) |
| COPD (2) | Coprocessed excipient (1) | Cordia obliqua (1) |
| Corneal opacities (1) | Coronally advanced flap (1) | Coronavirus disease (1) |
| Correlation (2) | Corticosteroid (2) | Corticosteroids (2) |
| Cosmetic (2) | Cosmetic products (1) | Cosmetics (1) |
| Cosmetics use-related adverse reactions (1) | Cosolvency (1) | Cost analysis (1) |
| Cost avoidance (1) | Cost Minimization (1) | Cost of illness (2) |
| Cost saving (1) | Cost-effectiveness analysis (1) | Cost. (1) |
| Costing Analysis. (1) | Cotton dust (1) | Cotton oil (1) |
| cotton pellet (1) | Cough (1) | Cough medicine (1) |
| cough. (1) | Counterfeit Pharmaceutical Products (1) | CPs (1) |
| Cramer’s Matrix method (1) | CRC (1) | Cream (1) |
| creatinine (1) | Crinum asiaticum (1) | CRISPR/Cas9 (1) |
| Critical Care Unit (CCU) (1) | Critical Material attributes (1) | Critical material attributes (CMAs) (1) |
| Critical Quality Attributes (1) | Critical quality attributes (CQAs) (1) | Critical Thinking (1) |
| cromolyn sodium (1) | Cronbach’s alpha (1) | Croscarmellose sodium (CCS) (1) |
| Crospovidone (1) | Crospovidone (CP) (1) | Cross carmellose sodium (1) |
| cross-linking agents (1) | Cross-sectional study (1) | Crossandra (1) |
| Croton zehntneri (2) | Crystallinity (2) | CTCAE (2) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
| Curcumin (3) | current indian scenario of drug interactions (1) | Curriculum (1) |
| curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) | Cutaneous reaction (1) |
| CXCR4 (1) | Cyclodextrin (1) | Cyclooxegenase-2 inhibitor (1) |
| Cyclooxygenase (2) | cyclophosphamide (1) | Cymbopogon citratus (1) |
| Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) | Cyst (1) |
| Cytochrome P 2C9 (1) | Cytosine (CYS) (1) | Cytotoxic (1) |
| Cytotoxic activity. (1) | Cytotoxic agents (1) | Cytotoxicity (3) |
| CZE (1) | D&C (1) | D-optimal design (1) |
| Daily Defined Dose (1) | Dammam (1) | Dapsone (1) |
| Data mining algorithms (1) | DDX3 (1) | Death Receptors (1) |
| Decision making (1) | Deep vein thrombosis (1) | deferasirox (1) |
| deferiprone (1) | Deficiency (1) | Definitive screening design (DSD) (1) |
| Degenerative disc disease (1) | Degradation (1) | Degradation studies (1) |
| Dehydrozingerone (1) | Delignification (1) | Delirium (2) |
| Dementia (1) | democratic government (1) | Dengue (1) |
| Dengue high fever (1) | Dental caries (4) | Dental Caries. (1) |
| Dental decay (1) | Dental implants (1) | dental management (1) |
| Dental Prosthesis (1) | Dental prosthesis. (1) | Dental Restoration (1) |
| Dental Students (1) | Dentistry (2) | dentistry. (1) |
| Dentists (1) | Denture Stomatitis (1) | Deodorants (1) |
| Dependence (1) | Depigmentant (1) | Depok Primary Health Care (1) |
| Deprescribing (1) | Depression (3) | Depression 1 (1) |
| Dermatology (1) | Dermatology life Quality Index (1) | Dermic implants (1) |
| Design of experiments (DoE) (1) | Design of experiments. (1) | desirability function (1) |
| Desirability index. (1) | Desmodium gangeticum (1) | Desolvation Method (1) |
| Detorsion (1) | Deuterium (1) | device safety (1) |
| dexamethasone (2) | Dexibuprofen (1) | Dextrin (1) |
| DIA (1) | Diabetes (8) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (14) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | diabetic dyslipidemia (1) | Diabetic nephropathy (1) |
| Diabetic retinopathy (1) | Diabetic Wound (1) | Diacerein (1) |
| DiaKure (1) | diclofenac (2) | Diclofenac SLN (1) |
| Diclofenac sodium (1) | Dicloxacillin sodium (1) | Dicots (1) |
| Dicyclomine (1) | differential scanning calorimetry (1) | diffuse transmittance (1) |
| Diffusion method (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) |
| Dip coating (1) | Diplotropis ferruginea (1) | direct compression (3) |
| Direct to consumer advertising (1) | Directly observed treatment short-course (1) | Directly observed treatment shortcourse (1) |
| Discharge against medical advice (DAMA) (1) | discharge orders (1) | DISCLE (1) |
| Discrepancies (1) | Discriminant analysis (1) | Disease (1) |
| Disease free survival (1) | disintegration (1) | disintegration time (1) |
| Disproportionality Analysis (1) | Dissolution (5) | dissolution enhancement (1) |
| Dissolution rate (1) | Diuretic (1) | Diuretic activity (2) |
| DMAIC (1) | DMH (1) | DNA barcoding (1) |
| DNA damage (1) | DNA fragmentation (1) | docking (6) |
| Docking studies (1) | docking. (1) | Doctor (1) |
| Documentation (1) | Documentation and records (1) | Donepezil hydrochloride (1) |
| Dopamine (1) | Dosage formulation (1) | Dosage regimen (1) |
| Dose-dependent (1) | DOTS (1) | DOTS plus (1) |
| Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
| DPP-IV (1) | DPPH Assay (1) | DPPH radical scavenging assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) |
| Drug (2) | Drug allergy tests (1) | Drug carriers (1) |
| Drug delivery (2) | Drug delivery denture (1) | Drug detailing (1) |
| drug disposal (2) | Drug drug interactions (1) | Drug Hypersensitivity (2) |
| Drug induced nephrotoxicity (1) | Drug Information and Literature Evaluation (1) | drug interaction (2) |
| Drug interaction (DI) (1) | drug interaction management (1) | Drug Interaction probability scale (1) |
| drug interactions (3) | Drug Policies (1) | Drug prescriptions (1) |
| Drug product (1) | Drug Related Problems (4) | Drug related side effects (1) |
| drug release (1) | Drug Resistance (2) | Drug risk ratio (1) |
| Drug safety (2) | Drug Safety. (1) | Drug therapy (1) |
| Drug utilization (3) | drug utilization study (1) | Drug utilization. (1) |
| drug-drug interactions (5) | Drug-related problem (2) | Drug-Related Side Effects and Adverse Reactions (1) |
| Drug-SLS tablets. (1) | Drugedrug interaction (1) | Drugs (3) |
| Drugs and Cosmetics rules (1) | Drugs of abuse (1) | drug–drug gliclazide (1) |
| Drug–drug interaction (1) | Dry extract cinnamon (1) | Drying techniques (1) |
| DSPC (1) | Dual control release (1) | Dual Therapy (1) |
| dual-target-directed drugs (1) | Dunaliella salina (1) | Dynamic (1) |
| Dyslipidemias (1) | Dysphagia (1) | E-Cigarettes (1) |
| E-pharmacy websites (1) | e-prescribing (1) | E. coli (1) |
| E.crispa (1) | Early-Related Complications (1) | Eastern province (2) |
| EC50 values (1) | Economic (1) | Economic burden (1) |
| Edaravone (1) | Eddy’s hot plate method. (1) | edema (1) |
| Edible flowers (1) | Editorial (24) | Education (3) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | Egfr (1) | egg albumin microspheres (1) |
| Elderly (1) | Elderly Patients (1) | Electrochemical (1) |
| electrolyte release (1) | electrolytes (1) | Electron beam radiation (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elevated plus-maze (1) |
| Elisa (1) | Ellman’s assay (1) | Emblica offi cinalis (1) |
| Emergency contraception (1) | Emodin (1) | Emotional (1) |
| Emotional domain (1) | Emulgel (2) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium (1) |
| Endothelium. (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental domain (1) | Environmental Factors (1) | Enzymatic hydrolysis (1) |
| Enzyme kinetics (1) | eosinophil (1) | Epicatechin (1) |
| Epigallocatechin (1) | Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) |
| Epigenetics (1) | epilepsy (5) | Epithelial ovarian cancer (1) |
| EQ-5D-5L (1) | EQ5D (1) | ER Matrix (1) |
| erbal drugs (1) | erice declaration (1) | Erythema (1) |
| Erythema multiforme (1) | Erythrina indica (1) | Erythrina variegata (1) |
| Erythrocyte sedimentation rate (1) | Erythroderma (1) | erythropoietin (2) |
| Escherichia coli (1) | Escitalopram oxalate (1) | esomeprazole (1) |
| Essential drugs (1) | Essential hypertension (2) | Essential medicine (1) |
| essential medicines (1) | essential oil (5) | essential oil composition (1) |
| Essential principles (1) | Esthetics Dental (1) | Estimated Glomerular Filtration Rate (1) |
| Estrogen receptor alpha (1) | Ethambutol (1) | Ethanol (1) |
| Ethanol extract (1) | ethanolic extracts (1) | Ethiopia (2) |
| ethnicity (2) | Ethnomedicine (1) | Ethosomes (1) |
| Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) | Ethyl acetate fraction (1) |
| ethyl cellulose (2) | ethylcellulose (3) | ethylene glycol (2) |
| Etiology (1) | Eucalyptus (1) | Eucalyptus hybrid (1) |
| Eucalyptus oil (2) | eudragit (2) | Eudragit RL 100 (1) |
| eudragit S100 (2) | Eudragit-L100 (1) | Eudragit® S100 (1) |
| Eugenol (1) | Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) |
| Evaluation (1) | Ex vivo tissue entrapment (1) | ex-vivo performance (1) |
| Ex-vivo permeation (1) | Ex-vivo study (1) | Exacerbation (1) |
| Excess Alcohol Consumption (1) | Excision wound model (1) | Expectoration (1) |
| experiences (1) | Experiential learning (1) | Experimental ischemic stroke (1) |
| experimental study (1) | Expired medicines (1) | Expiry drugs (1) |
| Exports (1) | Expression profile (1) | Extract (1) |
| Extrapyramidal side-effects (1) | extrinsic stains (1) | extrusion (1) |
| Eye lens (1) | Ezetimibe (2) | Fabaceae (2) |
| Facial implants (1) | Facial Pain (1) | Factor analysis (1) |
| factorial design (5) | Factors (1) | Factors associated with medication non-adherence (1) |
| Falcipain-2 (1) | Family Planning Services (1) | Family satisfaction (1) |
| family therapy (1) | famotidine (2) | fast disintegrating tablet (1) |
| Fast Disintegrating Tablets. (1) | Fast dissolving film (1) | Fast dissolving films (1) |
| Fast dissolving tablets (1) | Fasting serum insulin level (1) | Fat (1) |
| Fatty acid profile (1) | FC reagent (1) | FDA AERS Database (1) |
| FDA Approval (1) | Fenugreek (1) | Ferric reducing antioxidant power assay (1) |
| Ferritin (1) | Ferrous sulfate (1) | Fetal Case Report (1) |
| Fialuridine', (1) | Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) |
| Ficus deltoidea (1) | Ficus racemosa (1) | film (1) |
| film hydration (1) | First permanent molars (1) | Fixed drug eruption (1) |
| Flavone (1) | Flavonoid (3) | Flavonoid Compounds (1) |
| Flavonoid fraction (1) | flavonoids (3) | Flavoxate HCl (1) |
| FlK-1 (1) | Floating beads (1) | floating controlled drug-delivery system (1) |
| Floating Drug Delivery (1) | Floating drug delivery system (1) | floating lag time (1) |
| Floating tablets (1) | Floriculture (1) | fluoroquinoes (1) |
| Fluoxetine (1) | Flupritine maleate (1) | flurbiprofen (1) |
| Flux (2) | FMCG (1) | folkloric use (1) |
| Follow up treatment (1) | Food drug and cosmetic act (1) | Forced degradation (4) |
| Forced degradation studies (1) | forced swim test (1) | Formication (1) |
| Formulary (1) | Formulary. (1) | Formulation (4) |
| Formulation and development (1) | Fortification (1) | Fourier transform infra red spectroscopic (1) |
| FPG (1) | FPGEE (1) | Fraction (1) |
| Franz Diffusion Cell (3) | FrEA5 (1) | free radical scavenger (1) |
| Free radicals. (1) | Freeze-drying (1) | Freund’s complete adjuvant (1) |
| Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) | Frusemide-induced complications (1) |
| FTIR (5) | Fullerenes (1) | Fumes (1) |
| functions (1) | Fungal infections (1) | furosemide (1) |
| Future Health Care Professionals (1) | G6PD deficiency (1) | GABA (1) |
| Galacto-Oligosaccharide (GOS) (1) | Galic Acid (1) | gallic acid (3) |
| Galphimia glauca Clav (1) | Gamma irradiation (1) | Gamma scintigraphy (1) |
| Gangrenous (1) | Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) |
| Garcinia daedalanthera extract (1) | Garcinia imberti (1) | Garcinia imberti bourd (1) |
| Garcinia indica (1) | Garcinia latissima (1) | gaseous contact (1) |
| gastric treatment (1) | Gastric ulcer (1) | Gastro-retentive drug delivery system (1) |
| gastroprotection (2) | gastroretentive (1) | gastroretentive drug delivery system (1) |
| Gatot Soebroto hospital. (1) | GC-MS (1) | GC-MS analysis (2) |
| GC-MS. (1) | GDP (1) | Gelatin (1) |
| Gelling Capacity. (1) | Gels (1) | Gemcitabine HCl (GCH) (1) |
| gemfibrozil (1) | Gender (1) | Gender and HIV. (1) |
| Gene expression (1) | Gene expressions (1) | Gene modification (1) |
| Gene silencing (1) | General medicine (1) | Generic (2) |
| generic drugs (2) | Generic Medicine (1) | Generic medicines (2) |
| Generic name. (1) | Generic substitution (1) | Generics (1) |
| Genetic polymorphisms (1) | genetic Signature (1) | Genotoxin (1) |
| Genotype frequency (1) | Gentamicin (4) | gentamicin sulfate (2) |
| Geriatrics (3) | Gewald’s reaction (1) | GFAP (1) |
| Gibb’s reagent (1) | Gina criteria (1) | Ginger (1) |
| Gingival hyperplasia (1) | Gingival hypertrophy (1) | gingival pocket (1) |
| Gingival recession (1) | Gingival thickness (1) | Gladiolus segetum (1) |
| glibenclamide (4) | gliclazide (2) | Glidescore (1) |
| Glimepiride (2) | glimepride (1) | Glipizide (3) |
| glitazars (1) | Global education (1) | Global publications (1) |
| Glomerulonephritis (1) | Glucagon (1) | Glucocorticoids (1) |
| Glucosamine (1) | Glucosamine sulphate (1) | Glucose (1) |
| Glucose metabolism (1) | glucose tolerance test (1) | glutathione (1) |
| Glycemic Control (1) | Glycerin (1) | Glycerine (1) |
| Glyceryl monostearate (1) | Glycine max (1) | Glycosylated hemoglobin (HbA1c) (1) |
| Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) | Goal orientation (1) |
| Goldenhar syndrome (1) | good manufacturing practices (1) | Gotu kola leaves extract (1) |
| GPx (1) | Graft Rejection (1) | Graft Survival (1) |
| Grafting (1) | Grafts (1) | Gram negative (1) |
| Gram positive (1) | Gram-Negative Organisms (1) | Gram-Positive Organisms (1) |
| Grape seed extract (1) | Grape seed oil (1) | Grapes seed extract (1) |
| Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
| Green Tea Leaves Extract (2) | Grip strengthening test (1) | Griseofulvin (1) |
| GSH (2) | guanyl cyclase stimulator (1) | Guest Editorial (1) |
| Guidelines (1) | Gulf cooperation council (1) | Gum and fat fractions (1) |
| Gum arab (1) | Gymnema Sylvestre (2) | Gynura procumbens (1) |
| GYTS (1) | H+ (1) | H-460 (1) |
| H2 Receptor Antagonist (1) | H2O2 (1) | HAART (1) |
| Haematological (1) | Haemoglobin (1) | Haemolysis (1) |
| Haemolytic ratio. (1) | Hair dye. (1) | Hair Growth Activity (1) |
| Hair Tonic (1) | Hajj (1) | haloperidol (2) |
| Hand and Foot Syndrome (1) | hardness (1) | Haritaki (1) |
| harmacotherapy-based problems (1) | Harmonization (2) | Hartwigs Severity Assesment Scale (1) |
| Hazardous drugs (1) | HbA1C (2) | HBV (1) |
| HCT: Hydrocholrothiazide. (1) | HDAC4 (1) | HDAC7 (1) |
| head twitch (1) | Health benefits (1) | Health Care Coordination and Monitoring (1) |
| Health Care Costs (1) | Health care profession (1) | health care professionals (1) |
| health care students (2) | Health care. (1) | Health Education (1) |
| Health Expenditures (1) | Health Hazard (1) | Health informatics (1) |
| Health Information Technology (1) | Health Knowledge (1) | Health problems (1) |
| Health Professionals (1) | Health related quality of life (1) | Health risks (1) |
| Health Services Accessibility (1) | Health Status Indicators (1) | Healthcare (4) |
| healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
| Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
| heart failure (3) | Heart failure clinics (1) | Heat-shock (1) |
| Hematological parameters (1) | hematological toxicity (1) | Hematology (2) |
| Hematoma (1) | Hematopoietic progenitors (1) | Hemodialysis (2) |
| Hemoglobin (1) | Heparin (1) | hepatic impairment (1) |
| Hepatitis (1) | Hepatitis B (1) | Hepatitis B virus core protein (1) |
| Hepatocellular (1) | Hepatocurative (1) | hepatoprotective (2) |
| hepatoprotective activity (3) | Hepatotoxicity (1) | HER1 (1) |
| HER2 (1) | HER3 (1) | HER4 (1) |
| Herbal active ingredients (1) | Herbal drugs (1) | Herbal medications (1) |
| Herbal medicine (2) | herbal medicines (1) | Herbal therapy (1) |
| Herbaldb (1) | HET-CAM (1) | Heterocyclic compound (1) |
| Heterotopic Pregnancy (1) | Hex (1) | Hexane (1) |
| Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) | High fat diet (2) |
| High Fat Diet Model (1) | High impact resin (1) | high performance liquid chromatography (1) |
| high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) | High-fat diet (1) |
| high-performance liquid chromatography (2) | High-throughput screening (1) | Higher education (1) |
| highly active antiretroviral therapy (1) | Highly Cited Papers (1) | Himatanthus drasticus (1) |
| Hip Arthroplasty (1) | Hirsutism (2) | Histocompatibility. (1) |
| Histological studies. (1) | Histopathological studies (1) | Histopathology (2) |
| HIV (1) | HIV associated dementia. (1) | HIV-1 RT (1) |
| HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) | HL-60 and K-562 (1) |
| HLA (1) | HMG-CoA Reductase (1) | Homeopathic medicines (1) |
| Homeopathy (1) | homology modeling (1) | Honey (1) |
| Honeycomb (1) | Hordeum vulgare (1) | Hordeum vulgare hull (1) |
| Horticulture (1) | Hospital pharmacy (2) | hospitalized children (1) |
| hospitalized patients (1) | Hospitals (1) | host (1) |
| Host-guest interactions (1) | hot plate (1) | HP-ß Cyclodextrin complexes (1) |
| HPLC (9) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) |
| HPLC. (1) | HPMC (1) | HPMC capsules (1) |
| HPMC K100M (2) | HPMC K4M (1) | HPTLC (7) |
| HPTLC Fingerprinting (1) | HQLQ (1) | HRQoL (3) |
| HSV-1 (1) | Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) |
| human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) | Human Papillomavirus (1) |
| Human plasma (2) | human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) |
| Humanitarian device exemption. (1) | Hyaluronic acid (1) | Hydnocarpus Pentandra (1) |
| Hydralazine hydrochloride (1) | Hydroalcoholic (1) | hydrochlorothiazide (2) |
| Hydrochlorthiazide (1) | hydrogel (2) | Hydrogels (1) |
| hydrogen sulfide (1) | hydrogenated castor oil (1) | Hydrophilic drugs (1) |
| Hydrophillic sealants (1) | Hydrophobic sealants (1) | Hydrotrophy (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyapatite (1) | Hydroxyl radical (1) |
| hydroxypropyl cellulose (1) | hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (2) |
| Hydroxypropyl methylcellulose E15 (1) | Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) |
| Hydroxypropylmethylcellulose (1) | Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) |
| Hypercholestremia (1) | Hyperglycemia (1) | Hyperglycemic (3) |
| Hyperglycemic mice (1) | Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) |
| hyperoxaluria (1) | Hypersensitivity (1) | Hypersensitivity reaction (1) |
| hypertension (8) | Hypertension( HTN) (1) | Hypertensive’s (1) |
| Hyperthyroidism (1) | hypertriglyceridemia (2) | Hypertrophy (1) |
| Hyperzincuria (1) | Hyphenated system (1) | hypoglycemic (1) |
| Hypoglycemic activity (1) | hypolipidemic (1) | Hypomineralization (1) |
| Hypothyroidism (1) | Hypozincaemia (1) | IBD (1) |
| IBD - Inflammatory Bowel Disease (1) | IC50 (2) | ICH (2) |
| ICH guidelines (3) | ICP22 (US1) gene (1) | IL-17 (1) |
| IL-6 (2) | IL-MAE (2) | Illiterate (1) |
| Iloperidone (1) | image analysis (1) | imidazole (1) |
| Immediate release layer and Bioavailability (1) | Immune response (1) | Immune suppression (1) |
| immunocytochemistry (1) | Immunoinformatics (1) | Immunological response (1) |
| Immunomodulatory (2) | Immunomodulatory effect (1) | Impacted (1) |
| Improving (1) | Impurity (1) | Impurity related substances (1) |
| In silico (2) | in situ gelation (1) | in vitro (4) |
| In vitro kinetics (1) | In vitro penetration lotion (1) | In vitro penetration test (1) |
| In vitro Penetration Test. (1) | In vitro release (1) | In vitro–In vivo (1) |
| in vivo (1) | In vivo kinetics (1) | In-patien (1) |
| In-situ gel (1) | in-vitro dissolution study (1) | In-vitro skin permeation (1) |
| Inappropriateness (1) | Inclusion complex (1) | inclusion complexes (2) |
| indexed cost (1) | India (8) | India. (1) |
| Indian context (1) | Indian publications (1) | Indian Traditional medicine (1) |
| Indion 234 (2) | Indion resin (1) | indomethacin (2) |
| Indonesia (2) | Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) |
| Industry (2) | Inequality (1) | infarct size (1) |
| Infection prevention (1) | infective endocarditis (1) | infertility (1) |
| Infit and outfit indices (1) | inflammation (4) | inflammatory bowel disease (2) |
| Information need (1) | Information system (1) | Information Technology Officers (1) |
| Information tool (1) | Inhibitor MDM2 (1) | Inhibitory activity (1) |
| Injectable (1) | innovation ecosystems (1) | inorganic salts. (1) |
| Inquiry learning (1) | INR (1) | inß ammation (2) |
| inß ammatory bowel diseases (1) | Insilico anticancer screening (1) | insulin (6) |
| Insulin receptor (1) | Insulin regimen (1) | insulin resistance (1) |
| Insulin resistance. (1) | insulin use in primary care (1) | Insulinophobia (1) |
| Integrase inhibitor (1) | Integrated Courses (1) | integrated economic analysis (1) |
| Intellectual Property l (1) | Intellectual property rights (1) | intelligent tutoring (1) |
| Intensive care unit (1) | Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) |
| interaction (2) | interferon (1) | interleukins (1) |
| International Collaboration (1) | International HIV dementia scale (IHDS) (1) | international organization (1) |
| international organizations (1) | international trade (1) | Internet (1) |
| Internet pharmacy (1) | interpretation (1) | Interventional tool (1) |
| Interventions (1) | Intervertebral disc C4/5 and C5/6 (1) | Intracanal medicament (1) |
| Intranasal delivery (1) | intraocular presuure (1) | Intrauterine Pregnancy (1) |
| Intravenous (1) | inventory index (1) | inventory management (3) |
| Investigation (1) | investigators (1) | Invited Article (2) |
| Ion Gelation Method (1) | ion pair complex (1) | Ionic gelation (1) |
| Ionic liquid (3) | Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) |
| Ionizing radiation (1) | ionotropic gelation (1) | iontophoresis (2) |
| Ipsilateral symptoms (1) | Iraq (1) | Iridoid glycoside (1) |
| iron chelation therapy (1) | Irrational (1) | Irrigation (1) |
| Irvingia gabonensis (1) | isatin (3) | ischemia (1) |
| ischemia-reperfusion injury (1) | Ischemic (1) | ischemic heart disease (1) |
| ISO (1) | isoniazid (3) | isonicotinohydrazide (1) |
| Isoprinosine (2) | Isopropyl myristate (1) | isoproterenol (1) |
| isoxazoline (1) | itopride HCl (1) | JNC 8 Guidelines. (1) |
| Journal (1) | Jurkat (1) | K+-ATPase β subunit (1) |
| K+ATP channel (1) | K-CAPS (1) | K562 (1) |
| Kaffir lime (1) | Kajjali (1) | Kakoli (1) |
| Kalanchoe Pinnata (1) | KAP (2) | KAP study (1) |
| Kappa Concordant value (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kati chakrasana (1) | Kernel powder (1) |
| Ketamine (1) | Ketoprofen (1) | Ketorolac (1) |
| Ketorolac salt (1) | Key words: 5-FU (1) | Key words: Esomeprazole (1) |
| kidney (2) | Kidney Transplantation (1) | kinetic drug release (1) |
| Kinetic Modelling (1) | KMnO4 (1) | kneading method (1) |
| kneading technique (1) | knowledge (16) | Kojic acid (1) |
| Kumar’s score (1) | L-arginine (1) | L-Thyroxine (1) |
| L. acidophilus (1) | labeling (1) | Laboratory findings. (1) |
| Lactobacilli (2) | Lactobacillus (1) | Lag period (1) |
| Lagenaria siceraria (1) | Lantana camara (1) | Lantana montevidensis (1) |
| Larvacidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) |
| LC-MS (1) | LC-MS/MS (1) | LC/MS/MS (1) |
| LC50 (1) | LCMS/MS (1) | LC–MS/MS (1) |
| LDL-C (1) | Leaf (1) | Learning process (1) |
| leaves (4) | Leftover medicines, (1) | Leg Length (1) |
| Leptin (1) | Letter to Editor (4) | Letter to the Editor (3) |
| Letters to the Editor (6) | Leucaena leucocephala (1) | Leucas lavandulaefolia (1) |
| Levocetirizine (1) | Levodopa (1) | Lexicomp (1) |
| Lichen planus (1) | Licofelone (1) | Ligand-based drug design (1) |
| Lightening (1) | Limb Length (1) | Limbs (1) |
| lime fruit (1) | Linagliptin (1) | Lindernia ciliata (1) |
| Linezolid (1) | Linoleic acid (1) | lipid matrix (1) |
| lipid metabolism (2) | Lipid Microparticles (1) | lipid microspheres (1) |
| Lipid nanocrystals (1) | Lipid peroxidation (3) | lipid peroxides (1) |
| lipid profile (1) | Lipid profile membrane bound enzymes (1) | lipids (1) |
| lipoic acid (1) | liposome (1) | Lippia (1) |
| lithium toxicity (1) | Live-well™ (1) | liver function (2) |
| Liver necrosis (1) | Liver tonic (1) | Liver Transplantation (1) |
| Local drug delivery (1) | locomotor activity (1) | Long term memory (1) |
| Low-density lipoprotein cholesterol (1) | Lozenges (1) | Luffa echinata (1) |
| Lumbar Spinal Stenosis (1) | Luminesce (1) | Lung (1) |
| Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
| Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
| Lymphoma (1) | Lysozyme (1) | M. tuberculosis H37Rv (1) |
| Maceration (1) | Macromicroscopy study (1) | Macrophage (1) |
| Macrophage cell line (1) | Mahkoside A (1) | Major Contributed Organizations (1) |
| Malaysia (5) | Malaysia. (1) | Malaysian. (1) |
| Male (1) | Maleic Acid (1) | Malignant lesions (1) |
| Malignant transformation (1) | malondialdehyde (2) | Maltodextrin (2) |
| Mammary carcinoma (1) | Mandibular hypoplasia (1) | Mangiferin (1) |
| Mangosteen Peels (1) | manidipine dihydrochloride (1) | Mannich base (1) |
| Mannich Bases (1) | Marine fungi compounds (1) | Mast cell (1) |
| Maternal Care. (1) | Mathematical modeling (1) | matrix (1) |
| Matrix Tablet (1) | matrix tablets (3) | Maxillofacial complications (1) |
| MCF-7 (1) | MDA (2) | MDR-TB (2) |
| mean age (1) | Mechanism (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | Medical and non-medical (1) |
| medical costs (1) | Medical device (1) | Medical device recalls (1) |
| medical errors (1) | Medical informatics (1) | Medical Inpatients (1) |
| Medical practitioner (1) | Medical Representative (1) | Medical Respresntative (1) |
| Medical sales representative (1) | Medical students (2) | medication adherence (6) |
| medication adherence behaviour (1) | medication error (2) | Medication errors (2) |
| Medication non-adherence (1) | Medication reconciliation (1) | Medication regimen complexity (1) |
| medication safety (1) | Medication taking (1) | Medication understanding (1) |
| medication-/drug-related problem (MRP/DRP) (1) | Medicinal ornamental plants (1) | Medicinal plant (1) |
| Medicinal plants (4) | Medicine (2) | Medicine consumers (1) |
| Medicine disposal (1) | medicine-use practices (1) | Medicines storage (1) |
| Medicines wastage (1) | Mediterranean diet (1) | Melanesia (1) |
| Melastoma malabathricum (1) | Melinjo (2) | Meloxicam (1) |
| Memory (2) | Memory and learning. (1) | Men (1) |
| Menaquinone-4 (1) | Menstrual cycle (1) | Mental Disorders (1) |
| Mental health (2) | Mental health challenges (1) | Mental health services. (1) |
| Mentha arvensis (1) | mesalamine (1) | Metabolic ratio (1) |
| Metabolic syndrome (1) | Metabolism (1) | Metabolite profiling (2) |
| Metabomics (1) | metagenomic (1) | metformin (7) |
| metformin hydrochloride (1) | Methanol (1) | methanolic extract (1) |
| methocel (2) | method development (5) | Method optimization (1) |
| method validation (4) | Method validation Valsartan (1) | Methotrexate (1) |
| methyl orange (1) | methyl-b cyclodextrin (1) | metoprolol tartarate (1) |
| MetS (1) | Mevalonate (1) | MHCs (1) |
| Micelle (1) | Micro emulsion (2) | Micro particles. (1) |
| Micro-emulsion (1) | microbial contamination (1) | Microbiological (1) |
| Microbroth dilution (1) | Microcapsules (1) | microcrystalline cellulose (5) |
| microdilution (1) | Microdosing (1) | Microemulsion (1) |
| Microencapsules (1) | microneedles (1) | Micronucleus assay (1) |
| microparticles (1) | microsphere (1) | Microsphere Phytosome (1) |
| microspheres (6) | microtriches (1) | Microwave assisted extraction (1) |
| Microwave-Assisted Extraction (2) | miglitol (1) | Migraine (3) |
| migraine management, (1) | Mild neurocognitive disorder (1) | Milk (1) |
| Milnacipran (1) | Mimosa pudica (1) | Mineral trioxide aggregate (1) |
| minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) |
| mitochondria (1) | Mix mode (1) | MLR (1) |
| MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modafinil (1) | Modeling (1) |
| modern medicine (1) | modified melt dispersion technique (1) | Modified Starches (1) |
| MODY (1) | Mol inspiration (1) | Molar Incisor (1) |
| Molecular characterization (1) | Molecular docking (10) | molecular docking and anti cancer activity. (1) |
| Molecular Docking. (1) | Molecular Dynamic (1) | Molecular dynamics (3) |
| Molecular Dynamics Simulations (1) | Molecular Imprinted Polymer (1) | Molecular mimicry (1) |
| Momordica charantia (1) | Momordicin II Natural Products (1) | monoamine oxidase B (1) |
| Monocots (1) | Monophyletic (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morbidity (1) | Morin and validation (1) | Moringa oleifera (3) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Morocco (2) |
| Mortality (4) | Morus alba (2) | Mosquito repellent (1) |
| Mouth Dissolving Tablets (1) | mouth-dissolving film, (1) | MPO activity (1) |
| MPTP (1) | MRI Contrast agents (1) | MTT Assay (2) |
| MTT method (1) | MUC2 (1) | MUC6 (1) |
| Mucoadhesive (1) | Mucoadhesive agent (1) | mucoadhesive formulation (1) |
| Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) | mucodhesive (1) |
| Mulberry (1) | multi granules (1) | Multi Organ Failure (1) |
| multidrug resistant pathogens (1) | Multikinase Inhibitor (1) | multiparticulates (1) |
| multiparticulates dosage form (1) | Multiple myeloma (1) | Multiple Organ Dysfunction Syndromes (MODS) (1) |
| Multiple Organ Failure (1) | multiple regression (1) | multiple regression analysis (1) |
| Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) | Mycobacterium tuberculosis. (1) |
| Mycophenolate mofetil (1) | Mycophenolic acid (1) | Myeloperoxidase (1) |
| myocardial infarction (2) | Myomectomy. (1) | Myrica esculenta (1) |
| Myristicin (1) | Myrobalan (1) | N-aminoimidazoles (1) |
| N-napthyl ethylene diamine dihydrochloride (1) | Na+/K+-Atpase (1) | NABP (1) |
| NACO. (1) | Nadi shuddhi pranayama (1) | Naftopidil (1) |
| Naltrexone (1) | nano size (1) | Nanocellulose (1) |
| Nanocrystals (1) | Nanoemulsion (1) | Nanofibers (1) |
| Nanoformulation (2) | nanoformulations (1) | Nanonization. (1) |
| Nanopacticle (1) | Nanoparticle (3) | Nanoparticles (12) |
| Nanosuspension (1) | Nanosuspension tablets (1) | Nanosuspensions (1) |
| Naphthoquinone derivative (1) | NAPLEX (1) | naproxen (1) |
| Naranjo (1) | Naranjo algorithm (2) | Naranjo algorithm. (1) |
| Naranjo Causality Assessment (1) | Naranjo Probability Scale (1) | Naranjo’s ADR probability scale (1) |
| Narikel Lavan (1) | Narrow therapeutic index drugs (1) | Nasal delivery (1) |
| Nasal gel (1) | Nateglinide (1) | National Fomulary (1) |
| National Formulary (2) | National Health and Morbidity Surveys (1) | National Policy of Pharmaceutical Assistance (1) |
| National Public Health Programs (1) | Natural (1) | natural compounds (3) |
| Natural deep eutectic solvent (1) | Natural Polymers (1) | natural products (4) |
| NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) | nebivolol hydrochloride (1) |
| Necrosis. (1) | need assessment (1) | Neoplasm (1) |
| Nephropathy (1) | Nephroprotective (3) | Nephrotic syndrome (1) |
| Nephrotoxicity (1) | Nerium indicum (1) | neuropathy (1) |
| Neuroprotection (1) | Neuroprotective (1) | Neurosurgical (1) |
| neutropenia (1) | nevirapine (1) | new molecule (1) |
| Newborns (1) | Nicorandil (1) | Nicotine (1) |
| Nicotine dependence (1) | Nifedipine. (1) | Nigeria. (1) |
| nigrostriatal pathway (1) | Nil (12) | Nill (19) |
| Nimesulide (1) | niosome (1) | Niosomes (1) |
| Nitric acid (1) | Nitric oxide (5) | Nitrogen starvation (1) |
| Nitroglycerin (1) | NK cell (1) | NMDA (1) |
| NMDA receptors (1) | Noccik Kudinir (1) | Nodular skin lesions (1) |
| Non-linear (1) | non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) |
| Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) | nonamers. (1) |
| noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
| Nonomuraea longicatena (1) | nootropic (1) | Norfloxacin (1) |
| Normoglycemic rats (1) | northeast India (1) | Nose to brain delivery (1) |
| Nosocomial infections (1) | Nothopanax scutellarium (1) | Novel delivery (1) |
| Novel drug delivery system (1) | NSAIDs (2) | Nuclear medicine (1) |
| nuclear pharmacy (1) | Nucleo CMP (1) | Nude mice (1) |
| Nutmeg oil (1) | Nutraceuticals (1) | Nutrient starvation (1) |
| Nutrition (1) | Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) |
| Obesity (4) | Occupational health (1) | Ocimum gratissimum (1) |
| Odontopediatric (1) | Off-label (1) | offending drugs (1) |
| Okra Mucilage (1) | Olmesartan (1) | olmesartan medoxomil (1) |
| Omega-6 fatty acid (1) | Omeprazole. (1) | Omics (1) |
| Oncology. (1) | Oncopharmacists (1) | ondansetron (3) |
| ondansetron hydrochloride (1) | Online health screening (1) | Online pharmacies (1) |
| OPD – Outpatient Department. (1) | open field (1) | Open field task (1) |
| Ophthalmic (1) | ophthalmic delivery (1) | ophthalmic inserts (1) |
| Opinion (1) | Opportunities (1) | Opportunity (1) |
| Optimal stress (1) | optimization (9) | Oral bacteria (1) |
| Oral cancer (3) | Oral diagnosis (1) | Oral disease (1) |
| Oral diseases (1) | oral disintegrating tablets (1) | Oral glucose tolerance (1) |
| oral glucose tolerance test (3) | Oral hypoglycemic drugs (1) | oral insulin (1) |
| Oral manifestations (1) | Oral Medicine (1) | Oral Rehabilitation (1) |
| Oral route (1) | Oral Surgery (2) | Orally disintegrating tablets (1) |
| Organ Toxicities (1) | organic acids (1) | organogel (1) |
| Organophosphate (1) | ORIF (1) | Origanum vulgare (1) |
| Original Article (3) | Originator. (1) | Orlistat (2) |
| orodispersible tablet (1) | orodispersible tablets (2) | Oscillopsia (1) |
| Osmotic pump (1) | Osseointegration (1) | Osteoarthritis (3) |
| Osteoblast (3) | Osteoclast (2) | OTC switch (1) |
| Otomycosis (2) | Outcome therapy (1) | Outdoor patients (1) |
| Outpatient Pharmacy (1) | Outpatient Psychiatry (1) | Outpatients (1) |
| ovalbumin (1) | Ovarian (1) | Ovarian Cyst (1) |
| Over the counter (1) | Over-the-counter (1) | Overweight (1) |
| OVX (1) | Oxalic acid (1) | oxazepinone (1) |
| oxcarbazepine (1) | Oxidation (1) | oxidative damage (1) |
| oxidative stress (6) | Oxyresveratrol (2) | oxytetracycline (1) |
| P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
| P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p21SNFT (1) |
| p53 tumor suppressor gene (1) | Package insert (1) | Paediatric (2) |
| Paediatrics (1) | Pain (2) | Pain scale (1) |
| Pain. (1) | Painkiller (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (1) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (4) | Paracetamol. (2) | Paresis (1) |
| Parkinson’s disease (2) | partial least square (1) | particle size analysis (1) |
| PASS (1) | passive avoidance learning (1) | Patch (1) |
| patents (4) | Pathological response (1) | Patient (2) |
| Patient adherence. (1) | Patient Care (1) | patient counseling (1) |
| Patient counseling and Patient information leaflet (1) | patient education (2) | Patient health questionnaire (PHQ) (1) |
| Patient initiated adverse drug reporting (1) | Patient Safety (2) | Patient satisfaction (1) |
| Patient Satisfaction Questionnaire (1) | Patient Survival (1) | patient-physician communication (1) |
| Patient-safety (1) | patients (4) | Patients. (1) |
| paw edema (1) | Paw edema. (1) | Paw volume (1) |
| PE 18:0/18:0-PEG 2000 (1) | Pectin (1) | pedagogy (1) |
| Pediatric (3) | Pediatric cancer (1) | Pediatric Dentistry (1) |
| Pediatrics (1) | Pediculosis (1) | Pegagan extract (1) |
| PEGylation (1) | Pemphigus vulgaris (1) | Penang (1) |
| penetration (3) | penetration enhancer (1) | penetration pressure (1) |
| penicillamine (1) | Penicillins (1) | pentylenetetrazole (1) |
| PEO (1) | Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) |
| Peppas and Higuchi’s equations (1) | Peptic Ulcer. (1) | peptide vaccine (1) |
| Peptidoglycan (1) | percentage healing of wound area (1) | perception (9) |
| Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
| periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permanent (1) | Permeation (5) |
| Permeation enhancer (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) |
| Personal care products (2) | Persons and items reliability (1) | pH dependent approach (1) |
| pH independence (1) | pH-sensitive (1) | Phagocytosis (1) |
| Phaleria marcocarpha (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (2) | Pharmaceutical Care service (1) | pharmaceutical care. (1) |
| pharmaceutical formulations (1) | Pharmaceutical Industry (1) | Pharmaceutical Marketing (1) |
| Pharmaceutical Services (2) | Pharmaceutical-Care (1) | Pharmaceutical-industries (1) |
| Pharmaceutics (1) | Pharmacist (5) | Pharmacist intervention (1) |
| Pharmacist intervention. (1) | pharmacist role in public health (1) | Pharmacists (2) |
| pharmacists India (1) | Pharmaco epidemiology (1) | Pharmacodynamic (3) |
| Pharmacodynamic activity (1) | pharmacodynamics (2) | Pharmacogenetics (1) |
| Pharmacogenomics (1) | Pharmacognostic (1) | pharmacognostic standardization (1) |
| pharmacognostical (1) | Pharmacognosy (1) | pharmacognosy study (1) |
| Pharmacokinetic (7) | Pharmacokinetic interactions. (1) | pharmacokinetics (10) |
| Pharmacokinetics. (2) | Pharmacological properties (1) | Pharmacophore (3) |
| Pharmacosomes (1) | Pharmacotherapy (1) | Pharmacovigilance (19) |
| Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
| Pharmacovigillance (1) | pharmacy (6) | pharmacy curriculum (2) |
| Pharmacy education (1) | Pharmacy Enforcement Division (1) | Pharmacy informatics (1) |
| Pharmacy intervention (1) | Pharmacy practice (1) | Pharmacy services (1) |
| Pharmacy store (1) | Pharmacy student (1) | Pharmacy students (1) |
| Phase diagrams (1) | Phase I studies (1) | Phase rule (1) |
| phase solubility (1) | phase solubility profile (1) | Phenobarbitone (1) |
| Phenolic (1) | phenolic compounds (2) | Phenolic content (1) |
| phenolics (1) | phenols (1) | Phenothiazine (1) |
| Phenytoin (5) | Phenytoin cold cream (1) | Phenytoin Toxicity (1) |
| Pheritima posthuma (1) | Phleboliths (1) | Phoenix dactylifera (1) |
| Phospholipid E80 (1) | Phosphorylase kinase (1) | Photoprotection. (2) |
| Phthalates (1) | Phyllanthus emblica, (1) | Phyllanthus reticulatus (1) |
| Phylogenetic tree (1) | Phylogeny (1) | Physical activity (1) |
| Physical fitness (1) | Physical stability (1) | Physichochemical Characterization (1) |
| Physicians (5) | Physicochemical (1) | physicochemical evaluation (1) |
| physicochemical properties (1) | physiochemical descriptor (1) | Physiological role (1) |
| Phytochemical (2) | phytochemical prospection (1) | Phytochemical screening (1) |
| Phytochemicals (1) | Phytoconstituents (1) | Phytomolecule (1) |
| Phytopharmaceutical drug (1) | Phytosome (1) | picrotoxin (1) |
| pictograms (1) | Pilgrims (1) | PIM (1) |
| Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
| Piperidino thiophene (1) | Piperine (2) | Piroxicam (2) |
| Pits and Fissures (1) | Pixel intensity. (1) | Plackett-Burman (1) |
| Plackett-Burman design (1) | plant extracts (1) | plasma (3) |
| Plasma concentration (1) | plasma concentrations (1) | Plasma creatinine (1) |
| Plasma insulin (1) | Plasma urea (1) | plasma-brain correlation (1) |
| Plasma. (1) | Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) |
| Platelet aggregation. (1) | Platelet concentrates (1) | Platelet rich fibrin membrane. (1) |
| Pleiotropic effects (1) | PLGA (1) | PLS (1) |
| PLSR (1) | Pluronic (1) | Pluronic F 127 (1) |
| PM6 (1) | PM7 (1) | Pneumonia (2) |
| POGIL (1) | Point-measure correlation coefficients (1) | Poison (2) |
| Poisoning pattern (1) | Polarography (1) | Poloxamer 188 (1) |
| Poloxamer 407 (2) | Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) |
| Poly herbal (1) | poly(ε-caprolactone) (1) | Poly-herbal (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymer (1) | Polymeric nanoparticles (3) |
| Polymorphism (1) | polypharmacy (8) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
| Pomalidomide (1) | PON1 mRNA (1) | porosity (1) |
| Port-A Catheter. (1) | Portfolio (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Post marketing (1) | Post-antibiotic era (1) | Posterior reversible encephalopathy syndrome (1) |
| Potassium (1) | Potassium Channel (1) | Potassium chloride (1) |
| Potassium Nitrate (1) | Potential Drug-Drug Interaction (1) | Potentially malignant lesions (1) |
| Powder (1) | PPAR agonists (1) | PPARγ agonists. (1) |
| PPBG (1) | pPharmacokinetics (1) | PPP model (1) |
| practice (4) | practices (1) | pravastatin (1) |
| Pre ADMET (1) | pre prandial (1) | Pre University students (1) |
| Pre-authorization (1) | Prebiotic (2) | Precipitation (1) |
| precise (1) | Precision (1) | Predictors (2) |
| Pregabalin (1) | Pregnancy (4) | preliminary screening (1) |
| Premna esculenta (1) | prescriber (1) | Prescribing (2) |
| Prescribing errors (2) | Prescribing indicators (1) | Prescribing pattern and Prescription Quality (1) |
| Prescribing pattern. (1) | Prescription (3) | Prescription audit (1) |
| Prescription error. (1) | prescription monitoring (1) | prescription only medicines (1) |
| Prescription pattern (3) | Prescription refill (1) | Prescription review (1) |
| pressure dependent approach (1) | Prevalence (5) | Prevention. (1) |
| Price variation (1) | Primary health care (2) | Primary Health Care. (1) |
| Primary tooth (1) | Principal component analysis (1) | principal component regression (1) |
| Pristane (1) | Private Medical College (1) | PRO (1) |
| Probable (1) | Probiotic (1) | Probiotics (1) |
| Problem-based learning (1) | process capability (1) | Process parameters. (1) |
| Product Surveillance (1) | Products with Antimicrobial Action. (1) | progesterone (1) |
| Proniosomal gel (1) | Property Intellectual (1) | Prophylaxis (2) |
| propolis (4) | Proportional reporting ratio (1) | propranol hydrochloride (1) |
| Propranolol hydrochloride (1) | Prospection (1) | Prospective Study (2) |
| prostaglandins (1) | Prosthesis Coloring (1) | Proteasome activity (1) |
| protein proÞ le (1) | proteolytic enzymes (1) | Proton adduct (1) |
| Proton Pump Inhibitor (2) | Proton pump inhibitors (1) | Proton-pump Inhibitors (1) |
| Protransfersome (1) | Prteomics (1) | Pseudo ternary phase diagrams (1) |
| Pseudomonas aeruginosa (1) | Psidium Guajava (1) | Psychological mindedness (1) |
| Psychomotor (1) | Psychosis (2) | Psychotropic drugs (1) |
| Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
| Public behavior (1) | Public health hospital (1) | Public hospital (2) |
| Public Service (1) | Publication (1) | Publications (2) |
| Pulmonary Fibrosis (1) | pulmonary hypertension (1) | Pulmonary toxicity (1) |
| Pulpectomy (1) | Pulse wave velocity (1) | Punica granatum (2) |
| Pyrazinamide (1) | pyrazine (1) | pyrazoline (1) |
| pyrazolines (2) | Pyrimidine (1) | Q1F (1) |
| QOL (1) | QRS-T angle (1) | QSAR (3) |
| qualitative (1) | Qualitative analysis (1) | qualitative study (1) |
| Quality (1) | quality assurance (1) | Quality by design (QbD) (1) |
| Quality by design Ritonavir (1) | Quality Control (1) | Quality Indicators (1) |
| quality of internet information (1) | quality of life (7) | quantitative structure-activity relationship (1) |
| Quercetin (2) | Questionnaire (2) | quinazolin-4(3H)one (1) |
| quinazolinone (1) | Quinazolinone. (1) | quinoline derivatives (1) |
| R2 values (1) | Rabbit plasma (1) | Rabbits. (1) |
| radical scavenger (1) | Radical scavengers (1) | radicals (1) |
| Radiculopathy (1) | Radio-mitigation (1) | Radiology Unit (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raltegravir potassium (1) |
| Raman spectroscopy (2) | ramipril (2) | ranitidine (1) |
| Ranitidine hydrochloride (2) | Ranitidine’. (1) | ranolazine (1) |
| Ransmission electron microscopy (1) | Rapid disintegration (1) | Rasagiline mesylate (1) |
| Rat (1) | ratio test procedures (1) | Rational pharmacotherapy. (1) |
| Rational prescribing (1) | Rational Use (1) | Rational use of Medication (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | Re-emerging viral infections (1) | re-precipitation (1) |
| Reactants (1) | recognized standards (1) | recovery studies (1) |
| Red ginger (1) | Reduction (1) | Reflective pedagogy paradigm (1) |
| Reflux diseases (1) | reforms (1) | Regeneration (1) |
| Regression analysis (2) | Regressions statistics (1) | Regulation (1) |
| Regulations (1) | regulatory (2) | Regulatory affairs (1) |
| regulatory system (1) | Rehospitalisation (1) | Relative performance (1) |
| release kinetics (3) | Release studies. (1) | relese kinetics (1) |
| Removable denture (1) | Renoprotection (1) | Renoprotective (1) |
| repaglinide (2) | reperfusion (1) | Repurposing (1) |
| research (1) | Research Skills. (1) | reserpine (1) |
| Resident doctors (1) | Resistance (5) | Resistant starch (1) |
| Resource poor setting (1) | Respiratory tract (1) | Response Surface Methodology (3) |
| Response surface methodology. (1) | Response to antiretroviral therapy (1) | Resveratrol (2) |
| retail pharmacy (1) | Retention. (1) | Retinopathy (1) |
| retrospective cohort (1) | Retrospective study (3) | reversed-phase chromatography (1) |
| Rhabdomyolysis (1) | Rhaphidophora pinnata (1) | Rheumatology (1) |
| rhizomes (1) | Riboflavin (1) | Rice Bran Oil (1) |
| Rifampicin (2) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | Risk Estimation Matrix (1) | Risk factor. (1) |
| Risk factors (5) | Risk Factors. (1) | Risk rating (1) |
| Rituximab (1) | rivastigmine (1) | RNA interference (1) |
| RNAi (1) | RNAi technology (1) | RNTCP (2) |
| Rodenticides (1) | root (1) | Root canal filling materials (1) |
| Root canal infection (1) | Roots extract (2) | Ropinirole (1) |
| Roscoea purpurea (1) | rosuvastatin (2) | rosuvastatin calcium (1) |
| Rota rod test (1) | Royal Malaysian Custom Officer (1) | RP-HPLC (9) |
| RP-HPLC method (1) | RP-TLC/Densitometry (1) | RP-UFLC method (1) |
| RT-qPCR (1) | Rubus fraxinifolius (1) | Rubus rosifolius (1) |
| rupatadine (1) | rutin (1) | ß avonoids (2) |
| S. mutans (1) | S.salivarius (1) | S.sanguis (1) |
| Saccharin (1) | Safe handling guidelines (1) | Safety (1) |
| Safoof razyanaj (1) | Safoof-e- Binai (1) | Sage (1) |
| Sambung nyawa (1) | Saponin (2) | saponins (1) |
| Sappan wood (1) | Saraschandra (1) | Satisfaction (1) |
| Saudi Arabia (8) | Saudi National Pharmacovigilance Centre (Saudi NPC) (2) | Saussurea (1) |
| Saussurea lappa (1) | scanning electron microscopy (3) | Schizophrenia (3) |
| Scientific Advertisements (1) | Scientometrics (5) | sclerotherapy (1) |
| Scopolamine (1) | Scores. (1) | Se- DeM ODT Expert system (1) |
| Second-line agents (1) | Secondary Level (2) | Sedation (1) |
| Sedation in pediatric patients (1) | Sedation scale (1) | seizure outcome (1) |
| Seizures (1) | Selected area electron diffraction (1) | Self efficacy. (1) |
| Self medication (1) | Self-directed learning (1) | self-emulsifying drug delivery system (1) |
| Self-Harm (1) | self-medication (6) | Self-Nano Emulsifying Drug Delivery System (SNEDDS) (1) |
| self-nanoemulsification (1) | Selfmedication (1) | Semi-permanent hair dye (1) |
| senna spectabilis (1) | Sensitive (1) | sensory cortical activity. (1) |
| separation (1) | sepbox (1) | Septic shock (1) |
| Sequences distillation (1) | Sequential optimization (1) | Serum (1) |
| Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) | Serum Glutamic Oxaloacetic Transaminase (1) |
| Serum triglyceride (1) | Serum Vitamin D (1) | Serum. (1) |
| sesame oil (1) | severe febrile neutropenia (1) | Severe Neck Pain (1) |
| Severe sepsis (1) | Severity (2) | Sexual dysfunction in diabetes (1) |
| SF-36 (1) | SGLT-2 Inhibitor (1) | Shodhana (1) |
| Short Communication (3) | short-term memory (1) | Sida rhomboidea.Roxb (1) |
| Side effect (1) | Side effects (1) | signal detection (1) |
| Signal detection. (1) | Signs and Symptoms (1) | Signs and Symtoms (1) |
| Silver nanoparticles (1) | silymarin (1) | Similarity factor (1) |
| similarity factor (f2) (2) | simplex lattice (1) | Simplex Lattice Design (2) |
| simultaneous determination (2) | simultaneous extraction (1) | simvastatin (1) |
| simvastatin. (1) | Single nucleotide polymorphism (1) | sintering (1) |
| siRNA (1) | siRNA. (2) | SIRT1 (1) |
| Sirtuin (1) | Sitagliptin phosphate (1) | six sigma (1) |
| SJS (1) | Skin diseases (1) | Skin drug test (1) |
| Skin irritation (1) | Skin protection (1) | Skin whitening (1) |
| SLAM markers (1) | SLS (1) | Smix (1) |
| Smix. (1) | Smoking (1) | smoking cessation. (1) |
| Smoking. (1) | smooth muscle cells (1) | Snake bite (1) |
| SNEDDS (2) | sobatum (1) | Social Media (1) |
| Social sexual. (1) | Sociodemographic factors (1) | Socioeconomic status (1) |
| SOD (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (2) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Sodium Valproate (1) | Sofosbuvir (1) |
| Solanum nigrum (1) | Solanum trilobatum (1) | Solanum viarum (1) |
| Solanum xanthocarpum, (1) | Solasodine (1) | solid dispersion (5) |
| solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) |
| solubility (7) | Solubility enhancement (1) | Solubility. (1) |
| solvent casting (1) | solvent evaporation (4) | Solvent evaporation. (1) |
| sonication time (1) | sonophoresis (1) | Sorafenib (1) |
| Sources (1) | Spacedrepetition. (1) | spasmolytic (1) |
| speciÞ city (1) | Spectrometric (1) | spectrophotometry (2) |
| sperm count (2) | SPF (1) | Spiro compounds (1) |
| Spleen colony assay (1) | Spondylosis (1) | Sponge implantation (1) |
| sponge implantation assay (1) | sponsors (1) | Spontaneous-Reporting. (1) |
| Sprague Dawley (1) | spray drying (1) | SPSS 20. (1) |
| ST segment elevation (1) | stability (1) | stability indicating (1) |
| stability indicating and validation. (1) | Stability indicating assay (1) | Stability indicating assay method (1) |
| stability indicating method of artemether (1) | stability indicating. (1) | Stability of the physical properties (1) |
| Stability test (1) | stability. (1) | stain removal (1) |
| stakeholders (1) | Standardization (7) | Standardized Zscore (1) |
| Staphylococcus aureus (1) | Staphylococcus sciuri (1) | Starlac (1) |
| Statin pathway (1) | Statins. (1) | Statistical Modeling (1) |
| Statistical optimization (1) | Stelechocarpus burahol (1) | Stem bark extract (1) |
| Stephania hernandifolia (1) | Stereospermum suaveolens (1) | Stereospermum tetragonum (2) |
| Sterilization Procedures (1) | Steroidal alkaloid (1) | Steudnera colocasiifolia (1) |
| Stevens Johnson Syndrome (1) | Stevens-Johnson syndrome (1) | Stilbene (1) |
| Stimulantia (1) | Stimuli (1) | Stomatitis under prosthesis (1) |
| Strabismus surgery (1) | Streptococci (1) | Streptococcus mutans (4) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | Stress degradation (1) |
| stress studies (2) | stroke and cardiac pacemaker. (1) | Stroke prevention (1) |
| structural descriptor (1) | Structured Communication. (1) | Stryphnodendron rotundifolium (1) |
| students (3) | students’ residence (1) | Sub Clinical Hypothyroidism. (1) |
| Sub-acute Inflammation (1) | Subcutaneous fat (1) | sublingual films (1) |
| substituted acetophenones (1) | Succinic acid (1) | sucrase (1) |
| Sudan (1) | Sulfated polysaccharides (1) | Sulfonylurea (2) |
| Sulfonylureas (1) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunlight (1) | Sunscreens. (1) |
| Super disintegrants (1) | superdisintegrants (2) | Superdisintergrants (1) |
| Superoxide Dismutase. (1) | superoxidedismutase (1) | superporous hydrogel composite (1) |
| Supply Chain Management (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (2) | Surgery (2) |
| Surgical cutters (1) | surgical prophylaxis. (1) | Surgical. (1) |
| Survey questionnaire (1) | survey. (1) | Survival rate (1) |
| sustained release (3) | sustained release pellets (1) | sustained release. (1) |
| Susutained release layer (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (2) |
| swelling studies (1) | SWOT (1) | Symptoms (1) |
| Symptoms domain (1) | Synchronous spectrofluorimetry. (1) | Synergism. (1) |
| Synthesis (4) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) | Systematic review (2) |
| Systematic Review. (1) | Systemic steroids. (1) | Systems biotechnology (1) |
| Systolic dysfunction. (1) | T cell epitope (1) | T lymphocytes (1) |
| T regs (1) | Tab. Pardopa (1) | Tablet Compression (1) |
| Tacrolimus (1) | Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) |
| Tactile stimulation (1) | tail suspension test (1) | Tamarindus indica (1) |
| Tamilians (1) | Tamoxifen (1) | Target delivery (1) |
| Targeted drug delivery system (1) | taste masking (2) | tasteless complex (1) |
| taxane (1) | Taxanes (1) | Taxus baccata (1) |
| Teaching Hospital (1) | Technology (1) | technology-enhanced learning (1) |
| Tecoma stans (1) | tegument (1) | telmisartan (1) |
| Temporomandibular Joint (1) | Temporomandibular Joint Disoders (1) | TEN (1) |
| Tenatoprazole sodium (1) | Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) |
| Terminala bellerica (1) | Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) |
| Ternary phase diagram (1) | terpenoids (1) | Tertiary Care (1) |
| Tertiary care hospital (3) | testicular damage (1) | testosterone (3) |
| Tetrapreniltoluquinone (1) | thalassemia major (1) | therapeutic angiogenesis (1) |
| therapeutic dose (1) | therapeutic drug monitoring (2) | therapeutic effectiveness (1) |
| Therapeutic Policies (1) | Thermoreversible gel (1) | Third Molar (1) |
| Thixogel (1) | Thixotropic (1) | THP-1 (2) |
| Three component system (1) | thrombocytopenia (1) | Thrombolysed subjects (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | Thyme oleoresin (1) |
| Thyrotoxicosis. (1) | Tigecycline (1) | time dependent approach (1) |
| Time lag (1) | Timed release (1) | Tissue distribution (1) |
| TLC (1) | Tobacco (2) | Tobacco smoking (1) |
| tolbutamide (1) | Tolerance (1) | Tooth brush. (1) |
| Tooth brushing (1) | Tooth Demineralization (1) | Toothpaste (1) |
| Toothpaste. (1) | Topical delivery. (1) | Topical drug delivery system (1) |
| Topical. (1) | Total flavonoid (1) | Total flavonoid content (2) |
| Total phenolic (2) | Total phenolic content (1) | total polyphenolic content (1) |
| total quality management (1) | toxicity (5) | Toxicity. (2) |
| traditional medicine (2) | Training of Central sterile and supply department employees (1) | tramadol HCL (1) |
| Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) | Trans-resveratrol (1) |
| Transcriptomics. (1) | transdermal (2) | transfer latency (1) |
| Transfersome (2) | Transfersomes. (1) | Translation (1) |
| Transmucosal (1) | Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) |
| Treatment (1) | Treatment adherence. (1) | Treatment outcomes (1) |
| Treatment success rate (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
| Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
| Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
| trinitrobenzene sulfonic acid (1) | Triphala (1) | triple distilled water (1) |
| Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
| Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
| Trypsin (1) | TSLP (1) | Tuberculosis (5) |
| Tuberculosis/HIV (1) | Tumor response (1) | Turkey (1) |
| Turmeric (1) | Tween 80. (1) | Twisted (1) |
| Tylophora indica (1) | Tylophorinidine. (1) | type 2 diabetes (2) |
| Type 2 diabetes mellitus (1) | Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) |
| UACR (1) | UCPMP Guidelines (1) | Ultra-Fast Liquid Chromatography (UFLCDAD) (1) |
| Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) | Ultrasonography (1) |
| Unani (1) | Unani medicine (3) | Uncemented (1) |
| Underutilization of insulin. (1) | Unethical practices. (1) | Unique device identification (1) |
| Universities (1) | Unlicensed. (1) | Unnecessary use. (1) |
| Unused drugs (1) | Unused/Unwanted medicines (1) | UPLC-QToF-MS/MS (1) |
| UPLC/ESI-Q-TOF-MS/MS method Validation (1) | Urban area (1) | urea (2) |
| Uremic toxins (1) | Urinary Hydrogen Peroxide (1) | Urinary Tract Infection (1) |
| Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) | Urine volume (1) |
| urolithiasis (1) | Urtica dioica L (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine fibroids (1) | Uterine Perforation. (1) |
| UV derivative spectrophotometry (1) | UV detection (2) | UV Spectrophotometric method (1) |
| UV spectrophotometry (2) | UV Spectroscopy (1) | UV-spectrophotometric method (1) |
| UV-spectrophotometry (2) | UV-Vis spectroscopy (1) | Vaccine (1) |
| Vaccine design (1) | vada (1) | vaginal gel (1) |
| Vaginitis. (1) | Vakrasana (1) | validation (21) |
| Validation. (1) | Valium (1) | Valproate (1) |
| valsartan (1) | Vanillin (1) | Vanillosmopsis arborea. (1) |
| vascular bundle (1) | vascular permeability (2) | vascular progenitors (1) |
| VED analysis (3) | VED analysis. (2) | VEGFR-2 (1) |
| Velpatasvir (1) | Venetoclax (1) | Venography and Hemangioma (1) |
| Venous malformations (VMs) (1) | verapamil (3) | Verapamil HCl (1) |
| Viability (1) | Vincristine. (1) | Vinegar (1) |
| VIPPS (Verified Internet Pharmacy Practice Sites) (1) | Virtual Screening (1) | Viscosity (1) |
| visible Spectrophotometry (1) | visible spectroscopy (1) | Visual analogue scale. (1) |
| Visual Analogues Score. (1) | Vitamin B12 (1) | Vitamin D (3) |
| Vitamin D deficiency (2) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitex agnus Castus (1) |
| Vitex negundo (1) | Voltage–gated calcium channels (1) | Voriconazole (1) |
| warfarin (2) | Warning signs (1) | Water hyacinth (2) |
| web-based learning (1) | Weibull parameters (1) | West timor (1) |
| Western blot technique (1) | Wet gangrene (2) | wet granulation (2) |
| wetting time (1) | Wheat (1) | White/red patch (1) |
| WHO core indicators (1) | WHO prescribing indicator (1) | WHO-QOL BREF questionnaire (1) |
| WHO-UMC causality assessment system. (1) | Wilson disease (1) | Wistar rats. (1) |
| Withania somnifera. (1) | Withdrawal (1) | Women. (1) |
| Work protection (1) | Work Satisfaction (1) | World Anti-Doping Agency (1) |
| World Health Organization (1) | Worldwide (1) | Wound Healing (1) |
| Wound tissue healing (1) | Wrightia tinctoria (1) | writhing (1) |
| X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
| xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
| Xenografts (1) | Xenografts. (1) | XRD (1) |
| Xylitol (2) | Ylang-ylang (1) | Yoga (1) |
| Young (1) | Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) |
| Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
| zidovudine (2) | Zika virus (1) | zinc (1) |
| Zinc ion (1) | Zingiber officinale (1) | Zingiberaceae (1) |
| zopiclone (1) | [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) |
| Α-amylase (3) | α-glucosidase (2) | α-mangostin (1) |
| β amyloid protein (1) | β Amyloid1-42 (1) | β-carboline (1) |
| β-carotene production (1) | β-cyclodextrin (3) | γ-oryzanol (1) |
| γ-retroviral vector (1) | ε-amino groups (1) | |
